Pharmacokinetics of Lu AF35700 in Subjects With Renal Impairment
Status:
Terminated
Trial end date:
2019-07-24
Target enrollment:
Participant gender:
Summary
This study will evaluate the pharmacokinetics of Lu AF35700 after a single dose tablet to
subjects with renal impairment (kidney insufficiency) and compare that with healthy subjects